US FDA’s Push For Greater Transparency: What About Advisory Committees?

 
• By Michael McCaughan
  
Advisory committee meetings allowed the FDA to be more transparent about its concerns with applications under review. (Shutterstock)
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from HBW Insight Perspectives

More from HBW Insight